ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 196 filers reported holding ARRAY BIOPHARMA INC in Q1 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,781,000 | -70.3% | 125,000 | -68.4% | 0.20% | -70.8% |
| Q3 2018 | $6,004,000 | +5.3% | 395,000 | +16.2% | 0.69% | -12.3% |
| Q2 2018 | $5,702,000 | -13.7% | 339,804 | -16.1% | 0.79% | -21.7% |
| Q1 2018 | $6,610,000 | +27.5% | 405,000 | 0.0% | 1.00% | +65.1% |
| Q4 2017 | $5,184,000 | +4.1% | 405,000 | 0.0% | 0.61% | -14.5% |
| Q3 2017 | $4,982,000 | -15.0% | 405,000 | -42.1% | 0.71% | -28.5% |
| Q2 2017 | $5,859,000 | -6.4% | 700,000 | 0.0% | 1.00% | -18.6% |
| Q1 2017 | $6,258,000 | -20.9% | 700,000 | -22.2% | 1.22% | -38.9% |
| Q4 2016 | $7,911,000 | +30.2% | 900,000 | 0.0% | 2.00% | +102.5% |
| Q3 2016 | $6,075,000 | +569.8% | 900,000 | +318.6% | 0.99% | +643.6% |
| Q4 2015 | $907,000 | -43.2% | 215,000 | -38.6% | 0.13% | -34.8% |
| Q3 2015 | $1,596,000 | -72.3% | 350,000 | -56.2% | 0.20% | -63.9% |
| Q2 2015 | $5,768,000 | -15.3% | 800,000 | -13.4% | 0.56% | -20.3% |
| Q1 2015 | $6,809,000 | +47.8% | 923,922 | -5.1% | 0.71% | -9.7% |
| Q4 2014 | $4,607,000 | +47.7% | 973,922 | +11.4% | 0.78% | +103.9% |
| Q3 2014 | $3,120,000 | +140.0% | 873,922 | +206.6% | 0.38% | +20.3% |
| Q2 2014 | $1,300,000 | – | 285,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |